Labshake search
Citations for R&D Systems :
501 - 550 of 2705 citations for Recombinant Human TNFRSF17 protein Fc His tagged APC labeled since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... and human recombinant basic fibroblast growth factor (40 ng/ml; R&D Systems) on plates pre-coated with poly-l-ornithine (50 µg/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... and 10 ng/mL neuregulin-1 (recombinant human NRG-1; R&D Systems)) at 37°C in 5% CO2 ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant human epidermal growth factor (EGF) was from R&D Systems (Abingdon, UK).
-
bioRxiv - Cancer Biology 2021Quote: Recombinant human TGF-β1 and TGF-β2□was purchased from R&D Systems. miR-335 antagomirs were obtained from the following companies ...
-
bioRxiv - Cell Biology 2022Quote: Human recombinant TNFα was obtained from R&D Systems (Cat# 210-TA-020). Antibodies against Pink1 (6946S) ...
-
bioRxiv - Immunology 2022Quote: ... 2000ng/mL recombinant human (rh) IL32γ (4690-IL-025/CF, R&D Systems) or solvent control was given at the same time ...
-
bioRxiv - Neuroscience 2019Quote: ... 100ng/mL recombinant human fibroblast growth factor 8a (FGF-8a, R&D system) from day 2 to day 11 ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... and for the rhTrx group with recombinant human Thioredoxin-1 (R&D Systems; 2.5 mg/kg in 100 μL solution in 0.9% NaCl solution) ...
-
bioRxiv - Systems Biology 2020Quote: ... or recombinant human NRG-β1/HRG-β1 EGF domain (HRG; R&D Systems) for 5 min at 25°C ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human VEGFA165a and VEGFA165b were obtained from R&D Systems (Minneapolis, MN). Odyssey Blocking Buffer and an Odyssey Infrared Imager were purchased from LI-COR Biosciences (Lincoln ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant human RNF4 was purchased from R&D Systems (Cat. # E3-210-050). Recombinant human ubiquitin was purchased from R&D Systems (Cat ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Microbiology 2022Quote: ... the media contained 200 ng/mL of recombinant human IFNγ (R&D Systems). For M2 macrophages ...
-
bioRxiv - Neuroscience 2022Quote: ... Human recombinant IL-8 (catalog no. 208-IL-010, R&D Systems, USA) was used at a 5 ng/ml concentration ...
-
bioRxiv - Neuroscience 2023Quote: Exogenous IGF-1 Administration: Human recombinant IGF-1 (R&D Systems 291-G1) was reconstituted in sterile saline and 5µls (30µgSE ...
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Genetics 2023Quote: ... recombinant human EGF at 20 ng/mL (R&D systems #236-EG-200), and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant human (rh) TGF-β (10 ng/mL, R&D Systems, 7754-BH) was applied to NHLF cell line only to induce LOX expression ...
-
bioRxiv - Physiology 2023Quote: ... Cells were stimulated by addition of recombinant human IL-1β (R&D Systems) and/or filter-concentrated JAR cell conditioned media as indicated ...
-
bioRxiv - Bioengineering 2023Quote: ... or 1000 ng/mL of recombinant human IFN-γ (R&D Systems, 285IF100) and TNF-α (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant human SHH (high activity (R&D Systems: Cat # 8908-SH-005/CF), and fixed after indicated treatment durations and processed as described below ...
-
bioRxiv - Genetics 2023Quote: ... The calibrator is recombinant human GDF15 from R&D Systems (Bio-Techne, USA). MSD Ansh antibody Total GDF15 between batch imprecision based on in-house sample pool controls 10.2% at 552.4 pg/ml ...
-
bioRxiv - Pathology 2023Quote: ... were treated with recombinant human osteopontin (rhOPN; R&D Systems, 1433-OP-050) for 24 hours in serum and supplement-free growth medium (EGM ...
-
bioRxiv - Physiology 2023Quote: ... Activity of BCAT was assessed using recombinant human BCAT2 (rhBCAT2; R&D Systems)41 ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 ng/ml recombinant human Wnt3a (R&D Systems; day 1 and 2), 1 mM L-Glutamine (L-Glu ...
-
bioRxiv - Cancer Biology 2023Quote: ... Serum-deprived media ±recombinant human CCL8 or CCL15 (R&D Systems, Minnneapolis, MN) and ±5 μg/ml neutralizing antibodies for CCR1 ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant Human Interferon alpha 2a (IFN-alpha) was purchased from R&D systems. Cisplatin was purchased from Sigma-Aldrich.
-
bioRxiv - Cell Biology 2020Quote: ... The beads were removed by centrifugation and the phosphorylated GST-NEPHRIN and GST-NEPH1 were mixed with recombinant purified active SHP-2 (Recombinant Human SHP-2; Cat. No.: 1894-SH; R&D Systems) in the presence of phosphatase buffer (10mM HEPES ...
-
bioRxiv - Developmental Biology 2021Quote: ... BMP4 recombinant protein (R&D Systems, Catalog No. 314-BP-050) was diluted in 15% pluronic gel (prepared in PBS ...
-
bioRxiv - Cell Biology 2021Quote: Recombinant proteins used are mouse FGF23 (2629-FG, R&D Systems), mouse TNFα (410-MT ...
-
bioRxiv - Cell Biology 2020Quote: Recombinant Mouse M-CSF Protein (cat# 461-ML, R&D Systems)
-
bioRxiv - Bioengineering 2023Quote: ... The following recombinant target proteins were purchased from R&D Systems: CRP (1707-CR) ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Developmental Biology 2023Quote: ... Stock recombinant zebrafish BMP4 protein (R&D Systems 1128-BM-010) was reconstituted to 20 µg/mL in 0.1% bovine serum albumin (BSA ...
-
bioRxiv - Microbiology 2023Quote: ... 200ng of recombinant ANXA2 protein (Cat# 9409-AN, R&D Systems) diluted in PBS ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Pathology 2023Quote: The ROSAKIT WT human cell line (RRID:CVCL_5G49) was cultured in the presence of recombinant human SCF (80 ng/mL, R&D Systems), as described previously (23) ...
-
bioRxiv - Developmental Biology 2022Quote: ... mouse anti-human Pref-1/DLK1/FA1 APC-conjugated antibody (R&D Systems, FAB1144A; RRID:AB_2890004), and mouse anti-human CD10 (Biocare Medical ...
-
bioRxiv - Biochemistry 2022Quote: Antibodies used for flow cytometry included: mouse anti-human FAP-APC (R&D Systems, FAB3715A), sheep anti-human FAP (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... with or without 10 µg/ml Fc proteins (R&D Systems Inc.). Mouse T cells were enriched with EasySep™ Mouse T Cell Enrichment Kit (Miltenyi Biotec ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human TGF-β (7754-BH) was purchased from R&D Systems (Minneapolis, MI). It was reconstituted at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% BSA ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant pro-legumain (asparaginyl endopeptidase) was purchased from R&D Systems (2199-CY), activated per manufacturer instruction and active site titrated using MP-L01 inhibitor as described by Poreba et al ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...